The efficacy of zuranolone in postpartum depression and major depressive disorder: a review & number needed to treat (NNT) analysis

被引：3

作者：

Cha, Danielle S. ^{[1
,2
,3
,4
,5
]}

Kleine, Nicholas ^{[4
,6
]}

Teopiz, Kayla M. ^{[4
,6
]}

Di Vincenzo, Joshua D. ^{[3
,4
]}

Ho, Roger ^{[7
,8
]}

Galibert, Stephanie L. ^{[9
]}

Samra, Amrita ^{[5
]}

Zilm, Samuel P. M. ^{[5
]}

Cha, Rebekah H. ^{[10
]}

d'Andrea, Giacomo ^{[8
]}

Gill, Hartej ^{[3
,11
]}

Ceban, Felicia ^{[3
,4
,10
]}

Meshkat, Shakila ^{[3
]}

Wong, Sabrina ^{[3
,4
]}

Le, Gia Han ^{[3
,11
]}

Kwan, Angela T. H. ^{[3
,11
]}

Rosenblat, Joshua D. ^{[3
,4
,12
]}

Rhee, Taeho Greg ^{[13
,14
]}

Mansur, Rodrigo B. ^{[3
,4
]}

Mcintyre, Roger S. ^{[15
,16
,17
,18
,19
,20
,21
,22
,23
]}

机构：

[1] Royal Brisbane & Womens Hosp, Mental Hlth Serv, Brisbane, Qld, Australia

[2] Univ Queensland, Sch Clin Med, Royal Brisbane Clin Unit, Brisbane, Qld, Australia

[3] Brain & Cognit Fdn, Toronto, ON, Canada

[4] Univ Hlth Network, Toronto Western Hosp, Mood Disorders Psychopharmacol Dept, Toronto, ON, Canada

[5] Royal Brisbane & Womens Hosp, Metro North Hosp & Hlth Serv, Brisbane, Qld, Australia

[6] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada

[7] Natl Univ Singapore, Inst Hlth Innovat & Technol iHealthtech, Singapore, Singapore

[8] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy

[9] Logan Hosp, Dept Obstet & Gynaecol, Logan, Qld, Australia

[10] McMaster Univ, Michael G DeGroote Sch Med, Hamilton, ON, Canada

[11] Univ Toronto, Inst Med Sci, Toronto, ON, Canada

[12] Univ Toronto, Dept Psychiat, Toronto, ON, Canada

[13] Yale Sch Med, Dept Psychiat, New Haven, CT USA

[14] Univ Connecticut, Sch Med, Dept Publ Hlth Sci, Farmington, CT USA

[15] Univ Toronto, Dept Psychiat & Pharmacol, Toronto, ON, Canada

[16] Brain & Cognit Discovery Fdn BCDF, Toronto, ON, Canada

[17] Depress & Bipolar Support Alliance DBSA Board Dire, Board Chair, Chicago, IL USA

[18] Guangzhou Med Univ, Guangzhou, Peoples R China

[19] Korea Univ, Coll Med, Seoul, South Korea

[20] Univ Philippines, Coll Med, Manila, Philippines

[21] SUNY Upstate Med Univ, State Univ New York, Syracuse, NY USA

[22] Univ Calif Riverside, Sch Med, Dept Psychiat & Neurosci, Riverside, CA USA

[23] Univ Toronto, 77 Bloor St West,6th Floor Suite 617, Toronto, ON M5S 1M2, Canada

来源：

EXPERT OPINION ON PHARMACOTHERAPY | 2024年 / 25卷 / 01期

基金：

中国国家自然科学基金; 加拿大健康研究院;

关键词：

Zuranolone; SAGE217; depression; postpartum/postpartum depression; rapid-acting; neuroactive steroid; GABA(A); positive allosteric modulator; COGNITIVE FUNCTION; ALLOSTERIC MODULATORS; MENTAL-DISORDERS; CLINICAL-TRIAL; IMPACT; HARM; ALPHAXALONE; OUTPATIENTS; IMPAIRMENT; LIKELIHOOD;

D O I：

10.1080/14656566.2023.2298340

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Introduction: Major depressive disorder (MDD) is a common and debilitating mental illness. Postpartum depression (PPD) impacts women globally and is one of the most common complications of childbirth that is underdiagnosed and undertreated, adversely impacting the mental health of women, children, and partners. Available antidepressant medications require weeks to months before showing effect. In this setting, zuranolone, an oral neuroactive steroid and a positive allosteric modulator of GABA(A) receptors, is an attractive alternative as a rapid-acting antidepressant treatment.Areas covered: This article reviews zuranolone (SAGE217), focusing on available clinical studies in individuals with PPD and MDD. This paper adds to the extant literature by presenting the efficacy data as Number Needed to Treat (NNT) to facilitate indirect comparisons with other antidepressants.Expert opinion: Zuranolone is a novel rapid-acting (i.e. two week course) oral antidepressant for the treatment of adults with PPD with ongoing clinical trials evaluating its efficacy in adults with MDD. Zuranolone is well tolerated with no significant safety concerns in any clinical trials completed to date. Zuranolone will be scheduled by the Drug Enforcement Agency (DEA).

引用

页码：5 / 14

页数：10

共 50 条

[41] The Centrality of Depression and Anxiety Symptoms in Major Depressive Disorder Determined Using a Network Analysis
Park, Seon-Cheol
Kim, Daeho
JOURNAL OF AFFECTIVE DISORDERS, 2020, 271 : 19 - 26
[42] Sleep and major depressive disorder: a review of non-pharmacological chronotherapeutic treatments for unipolar depression
Cunningham, Jasmyn E. A.
Stamp, Jennifer A.
Shapiro, Colin M.
SLEEP MEDICINE, 2019, 61 : 6 - 18
[43] The Centrality of Depression and Anxiety Symptoms in Major Depressive Disorder Determined Using a Network Analysis
Park, Seon-Cheol
Kim, Daeho
BIOLOGICAL PSYCHIATRY, 2020, 87 (09) : S230 - S230
[44] Efficacy of non-invasive brain stimulation and neuronavigation for major depressive disorder: a systematic review and meta-analysis
Valter, Yishai
Rapallo, Fabio
Burlando, Bruno
Crossen, Miah
Baeken, Chris
Datta, Abhishek
Deblieck, Choi
EXPERT REVIEW OF MEDICAL DEVICES, 2024, 21 (07) : 643 - 658
[45] Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
M Kato
A Serretti
Molecular Psychiatry, 2010, 15 : 473 - 500
[46] Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: A meta-analysis
Na, Kyoung-Sae
Lee, Kang Joon
Lee, Ji Sung
Cho, Young Sung
Jung, Han-Yong
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2014, 48 : 79 - 85
[47] Effectiveness of yoga for major depressive disorder: A systematic review and meta-analysis
Wu, Yufei
Yan, Danni
Yang, Jianli
FRONTIERS IN PSYCHIATRY, 2023, 14
[48] Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
Kato, M.
Serretti, A.
MOLECULAR PSYCHIATRY, 2010, 15 (05) : 473 - 500
[49] Transcranial and systemic photobiomodulation for major depressive disorder: A systematic review of efficacy, tolerability and biological mechanisms
Caldieraro, Marco A.
Cassano, Paolo
JOURNAL OF AFFECTIVE DISORDERS, 2019, 243 : 262 - 273
[50] Efficacy of inpatient psychotherapy for major depressive disorder: a meta-analysis of controlled trials
Schefft, C.
Guhn, A.
Brakemeier, E. -L.
Sterzer, P.
Koehler, S.
ACTA PSYCHIATRICA SCANDINAVICA, 2019, 139 (04) : 322 - 335

← 1 2 3 4 5 →